Showing results (521-530 of 3,635) with videos related to
Sort By:
Pageof 364
Breast (Edinburgh, Scotland)|January 9, 2018
A nationwide registry-based cohort study of the MammaPrint genomic risk classifier in invasive breast cancerFloris H Groenendijk, Agnes Jager, Fatima Cardoso, et al.Breast (Edinburgh, Scotland)|November 5, 2017
Effect of prophylactic betablocker or ACE inhibitor on cardiac dysfunction & heart failure during anthracycline chemotherapy ± trastuzumabDorothy M Gujral, Guy Lloyd, Sanjeev BhattacharyyaBreast (Edinburgh, Scotland)|November 4, 2017
Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors - Data from the German PRAEGNANT breast cancer registryAndreas D Hartkopf, Jens Huober, Bernhard Volz, et al.Breast (Edinburgh, Scotland)|February 8, 2018
Comparison of failure patterns between tubular breast carcinoma and invasive ductal carcinoma (KROG 14-25)Won Kyung Cho, Doo Ho Choi, Jieun Lee, et al.Breast (Edinburgh, Scotland)|January 12, 2018
First-line vs second-line fulvestrant for hormone receptor-positive advanced breast cancer: A post-hoc analysis of the CONFIRM studyAngelo Di Leo, Guy Jerusalem, Roberto Torres, et al.Breast (Edinburgh, Scotland)|December 12, 2018
Effects of adjuvant chemotherapy in T1N0M0 triple-negative breast cancerYi-Xing Ren, Shuang Hao, Xi Jin, et al.Breast (Edinburgh, Scotland)|December 24, 2018
Tackling the diversity of breast cancer related lymphedema: Perspectives on diagnosis, risk assessment, and clinical managementAnna Michelotti, Marco Invernizzi, Gianluca Lopez, et al.Breast (Edinburgh, Scotland)|December 16, 2018
The role of histone deacetylase inhibitors in metastatic breast cancerBruna Zucchetti, Andrea Kazumi Shimada, Artur Katz, et al.Breast (Edinburgh, Scotland)|January 15, 2019
A real-life study on the implementation and effectiveness of exemestane plus everolimus per hospital type in patients with advanced breast cancer. A study of the Southeast Netherlands Advanced Breast Cancer registryL M Knapen, S M E Geurts, K I E Ibragimova, et al.Pageof 364